Cargando…
Randomized controlled trial of effectiveness of lafutidine versus pantoprazole in uninvestigated dyspepsia
OBJECTIVES: Lafutidine is a new H(2)-blocker in India claimed to be more potent and effective than existing H(2)-blockers. Proton pump inhibitors (PPIs), by virtue of their mechanism of action, have greater efficacy than H(2)-blockers in gastric acid suppression. However, clinical trials comparing H...
Autores principales: | Maity, Somnath, Choudhury, Supriyo, Hazra, Avijit, Das, Amal Kanti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175885/ https://www.ncbi.nlm.nih.gov/pubmed/25298578 http://dx.doi.org/10.4103/0253-7613.140580 |
Ejemplares similares
-
Lafutidine 10 mg versus Rabeprazole 20 mg in the Treatment of Patients with Heartburn-Dominant Uninvestigated Dyspepsia: A Randomized, Multicentric Trial
por: Dewan, Bhupesh, et al.
Publicado: (2011) -
Endoscopic findings in uninvestigated dyspepsia
por: Faintuch, Jacob Jehuda, et al.
Publicado: (2014) -
Epidemiology of Uninvestigated and Functional Dyspepsia in Asia: Facts and Fiction
por: Ghoshal, Uday C, et al.
Publicado: (2011) -
Analysis of the Gastrointestinal Symptoms of Uninvestigated Dyspepsia and Irritable Bowel Syndrome
por: Hori, Kazutoshi, et al.
Publicado: (2009) -
A New Approach to the Management of Uninvestigated Dyspepsia in Primary Care
por: Salihefendic, Nizama, et al.
Publicado: (2015)